To validate the roles of hsa-let-7i and TRAF1 in TAM therapy, we knocked down TRAF1 with siRNA, separately we also over-expressed hsa-let-7i with its mimic in a breast cancer cell line, ZR-75-1. Here, TRAF1 is linked to breast carcinoma.